The addition of ICI had a favorable association with PFS (P = 0.031) (Fig. S3A) and favorable trend with OS (P = 0.40) (Fig. S3B) in the CD8-high group but not the CD8-low group (data not shown) for the patients with SCLC-A. This evidence concerns the gene CD8A and small cell lung carcinoma.